Literature DB >> 938964

Screening of malignant hyperthermia susceptible families by creatine phosphokinase measurement and other clinical investigations.

B A Britt, L Endrenyi, P L Peters, F H Kwong, L Kadijevic.   

Abstract

We investigated 56 families afflicted with malignant hyperpyrexia. One hundred and twenty-four individuals within these families had had an episode of malignant hyperthermia, of whom we saw seventy-two. Serum creatine phosphokinase (CPK) was statistically higher in affected individuals and in close relatives than in normal volunteers. The magnitude of the serum CPK elevations varied significantly between families. While in some families the serum CPK was clearly elevated in affected individuals, in other families the serum CPK was normal or only moderately or inconsistently raised. In these latter families serum CPK measurement was therfore of little or no value in identifying afflicted members. The incidence of musculoskeletal abnormalities was greater in affected individuals and in close relatives than in the general population. Thus, the concomitant individual belonging to a family known to be susceptible to malignant hyperthermia was a better indicator of the MH trait than was the presence of only one of these parameters. For reasons which we do not fully understand, MHS individuals were found to require fewer anaesthetics than normal persons. The incidence of MH crises within each family fell significantly following investigation, counselling, and issuance of Medic-Alert bracelets.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 938964     DOI: 10.1007/bf03005702

Source DB:  PubMed          Journal:  Can Anaesth Soc J        ISSN: 0008-2856


  55 in total

1.  SERUM CREATINE PHOSPHOKINASE (CPK) ACTIVITY IN DISORDERS OF HEART AND SKELETAL MUSCLE.

Authors:  J W HESS; R P MACDONALD; R J FREDERICK; R N JONES; J NEELY; D GROSS
Journal:  Ann Intern Med       Date:  1964-12       Impact factor: 25.391

2.  Requirement for calcium in the synaeresis of myofibrils.

Authors:  A WEBER; R HERZ
Journal:  Biochem Biophys Res Commun       Date:  1961-12-20       Impact factor: 3.575

3.  Immunohistochemical study of creatine phosphokinase in pathological human muscle.

Authors:  G Karpati; A L Sherwin
Journal:  J Neurol Sci       Date:  1971-10       Impact factor: 3.181

4.  Serum enzyme studies in inherited disease of skeletal muscle.

Authors:  W H Thomson
Journal:  Clin Chim Acta       Date:  1971-11       Impact factor: 3.786

5.  The role of the sulfhydryl groups of tropomyosin and troponin in the calcium control of actomyosin contractility.

Authors:  B Yasui; F Fuchs; F N Briggs
Journal:  J Biol Chem       Date:  1968-02-25       Impact factor: 5.157

6.  Reversible change in physical state of troponin induced by calcium ion.

Authors:  T Wakabayashi; S Ebashi
Journal:  J Biochem       Date:  1968-11       Impact factor: 3.387

7.  Creatine phosphokinase in motor neurone disease.

Authors:  E R Williams; A Bruford
Journal:  Clin Chim Acta       Date:  1970-01       Impact factor: 3.786

8.  Isoenzymes of creatine phosphokinase in tissue extracts and in normal and pathological sera.

Authors:  K J van der Veen; A F Willebrands
Journal:  Clin Chim Acta       Date:  1966-03       Impact factor: 3.786

9.  Serum levels of ATP: creatine phosphotransferase (creatine kinase). The normal range and effect of muscular activity.

Authors:  P D Griffiths
Journal:  Clin Chim Acta       Date:  1966-04       Impact factor: 3.786

10.  Malignant hyperpyrexia. Further muscle studies in asymptomatic carriers identified by creatinine phosphokinase screening.

Authors:  H Isaacs; M B Barlow
Journal:  J Neurol Neurosurg Psychiatry       Date:  1973-04       Impact factor: 10.154

View more
  7 in total

1.  The in-vitro caffeine contracture test: influence of the muscle histochemical profile on test results.

Authors:  A K Brownell; M Szabo
Journal:  Can Anaesth Soc J       Date:  1982-05

2.  Malignant hyperthermia.

Authors:  B A Britt
Journal:  Can Anaesth Soc J       Date:  1985-11

3.  Perfusion of malignant hyperthermia susceptible and normal isolated pig livers with halothane.

Authors:  B A Britt; B Shandling; L Endrenyl; G M Kent
Journal:  Can Anaesth Soc J       Date:  1978-09

4.  The adenosine triphosphate (ATP) depletion test: comparison with the caffeine contracture test as a method of diagnosing malignant hyperthermia susceptibility.

Authors:  B A Britt; L Endrenyi; W Kalow; P L Peters
Journal:  Can Anaesth Soc J       Date:  1976-11

5.  Porcine malignant hyperthermia--failure of dantrolene dose response to diagnose susceptibility (halothane effect).

Authors:  E H Flewellen; T E Nelson; D E Bee
Journal:  Can Anaesth Soc J       Date:  1980-01

6.  Erythrocyte osmotic fragility testing and the prediction of canine malignant hyperthermia susceptibility.

Authors:  P H Cribb; E A Olfert; F B Reynolds
Journal:  Can Vet J       Date:  1986-12       Impact factor: 1.008

7.  Malignant Hyperthermia and Idiopathic HyperCKemia.

Authors:  Pashtoon Murtaza Kasi
Journal:  Case Rep Med       Date:  2011-11-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.